Skip to main content

Table 3 Related factors for positive β2-GPI antibody in non-AIP CP patients [n(%)]

From: Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients

Predictors

Positiven(n = 51)

Negetive(n = 506)

P

Female sex

15(29.4)

149(29.4)

0.996

BMI, kg/m2

21.49 ± 3.06a

25.23 ± 93.39

0.775

Age at the onset of CP, ya

40.31 ± 18.54a

36.22 ± 16.36

0.093

Age at the diagnosis of CP, ya

46.09 ± 15.33a

41.07 ± 15.15

0.135

Etiology

0.410

 ACP

6(11.8)

106(20.9)

 

 ICP

41(80.4)

351(69.4)

 

 Abnormal anatomy of pancreatic duct

1(2.0)

28(5.5)

 

 Hereditary CP

3(5.9)

19(3.8)

 

 Post-traumatic CP

0(0)

2(0.4)

 

Pancreatic stones

46(90.2)

470(92.9)

0.675

Adolescent

5(9.8)

67(13.2)

0.486

DM

22(43.1)

113(22.3)

0.001

Steatorrhea

14(27.5)

118(23.3)

0.508

Common bile duct stricture

11(19.6)

37(7.3)

0.006

PPC

8(15.7)

86(17.0)

0.812

SAP

2(3.9)

15(3.0)

1.000

Onset manifestations

0.110

 Abdominal pain

35(68.6)

401(79.2)

 

 Pancreatic insufficiency

10(19.6)

78(15.4)

 

 Others

6(11.8)

27(5.3)

 

Type of pain

0.576

 None

7(13.7)

50(9.9)

 

 Repeat attacks of acute pancreatitis

14(27.5)

151(29.8)

 

 Repeat pain

21(41.2)

174(34.4)

 

 Repeat acute attacks and pain

7(13.7)

89(17.6)

 

 Chronic pain

2(3.9)

42(8.3)

 

Drinking history (g/d)

0.078

 0

38(74.5)

315(62.3)

 

  < 20

1(2.0)

17(3.4)

 

 20~80

5(9.8)

58(11.5)

 

  > 80

7(13.7)

116(22.9)

 

Smoking history, pack-year

0.020

 0

39(76.5)

303(59.9)

 

 < 60

11(21.6)

182(36.0)

 

 ≥ 60

1(2.0)

21(4.2)

 

DM in first−/second−/third-degree relatives

3(5.9)

82(16.2)

0.051

Pancreatic diseases in first−/second−/third-degree relatives

0(0)

19(3.8)

0.316

Elevated IgGb

3(5.9)

16(3.2)

0.538

Elevated IgG4b

5(9.8)

16(3.2)

0.047

  1. CP Chronic pancreatitis, ACP Alcoholic chronic pancreatitis, AIP Autoimmune pancreatitis, ICP Idiopathic chronic pancreatitis, DM Diabetes mellitus, PPC Pancreatic pseudocyst, SAP Severe acute pancreatitis
  2. aMean ± SD
  3. bSerum IgG and IgG4 were measured by immunoturbidimetry assay (Immage800 specific protein analyzer, Beckman, USA; BN2 specific protein analyzer, Siemens, Germany), and their upper limits were 15.6 g/l, 2.0 g/l respectively